Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

SOLENO THERAPEUTICS INC (SLNO)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Mar-31-23Dec-31-22Sep-30-22Jun-30-22Mar-31-22Dec-31-21Sep-30-21
   10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q
Revenues  0.00.00.00.00.00.00.00.0
            Revenue growth       -100.0%  
Cost of goods sold  0.00.00.00.00.00.00.00.0
Gross profit  0.00.00.00.00.00.00.00.0
            Gross margin          
Selling, general and administrative   [+]8.68.55.66.26.85.83.08.3
Research and development          
Other operating expenses  -0.3-0.2-0.2-0.2-0.1-0.1-0.2-0.2
EBITDA   [+]-7.8-7.8-4.9-5.5-6.2-5.2-2.3-7.6
            EBITDA margin          
Depreciation and amortization  0.50.50.50.50.50.50.50.5
EBIT   [+]-8.3-8.2-5.4-6.0-6.7-5.7-2.8-8.1
            EBIT margin          
Other income (expense), net   [+]-0.1-0.1-0.1-0.1-0.10.00.00.0
Pre-tax income  -8.5-8.4-5.5-6.1-6.7-5.7-2.8-8.1
Income taxes  0.00.00.00.00.00.00.00.0
            Tax rate  0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income  -8.5-8.4-5.5-6.1-6.7-5.7-2.8-8.1
            Net margin          
   
Basic EPS   [+]($0.81)($0.88)($0.65)($0.76)($0.72)($1.07)($0.53)($1.53)
Diluted EPS   [+]($0.81)($0.88)($0.65)($0.76)($0.72)($1.07)($0.53)($1.53)
   
Shares outstanding (basic)   [+]10.49.48.48.19.35.35.35.3
Shares outstanding (diluted)   [+]10.49.48.48.19.35.35.35.3
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy